Literature DB >> 17434503

Recombinant follicle-stimulating hormone (rFSH) supplemented with low-dose human chorionic gonadotropin compared with rFSH alone for ovarian stimulation for in vitro fertilization.

Anne K Van Horne1, G Wright Bates, Randal D Robinson, Nancy J Arthur, Anthony M Propst.   

Abstract

Low-dose hCG supplementation was administered at the start of ovarian stimulation, concomitantly with recombinant FSH (rFSH) in GnRH antagonist cycles, and these were compared with GnRH-a cycles that used rFSH alone. The low-dose hCG group had similar implantation and pregnancy rates but had significantly reduced rFSH requirements, allowing for an average cost savings of $600 per cycle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434503     DOI: 10.1016/j.fertnstert.2006.12.051

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  Efficacy of low dose hCG on oocyte maturity for ovarian stimulation in poor responder women undergoing intracytoplasmic sperm injection cycle: a randomized controlled trial.

Authors:  Tahereh Madani; Ladan Mohammadi Yeganeh; Shabnam Khodabakhshi; Mohammad Reza Akhoond; Fatemeh Hasani
Journal:  J Assist Reprod Genet       Date:  2012-09-07       Impact factor: 3.412

2.  Randomized, Controlled Pilot Study of Low-Dose Human Chorionic Gonadotropin Administration Beginning From the Early Follicular Phase for Women With Polycystic Ovarian Syndrome Undergoing Ovarian Stimulation Using the Progesterone Protocol.

Authors:  Xiuxian Zhu; Yonglun Fu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-13       Impact factor: 5.555

3.  Effects of human menopausal gonadotropin on zona pellucida and pregnancy outcomes of ovarian stimulation protocols.

Authors:  Bing He; Cheng Junping; Huang Li; Tan Weihong; Xue Lintao; Wang Shikai
Journal:  Iran J Reprod Med       Date:  2015-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.